User profiles for Eli Mansour
 | ELI MANSOURMedical Assistant, State University of Campinas Verified email at fcm.unicamp.br Cited by 1783 |
[PDF][PDF] Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis
COVID-19 can result in severe lung injury. It remained to be determined why diabetic individuals
with uncontrolled glucose levels are more prone to develop the severe form of COVID-…
with uncontrolled glucose levels are more prone to develop the severe form of COVID-…
[HTML][HTML] Safety and outcomes associated with the pharmacological inhibition of the kinin–kallikrein system in severe COVID-19
E Mansour, AC Palma, RG Ulaf, LC Ribeiro… - Viruses, 2021 - mdpi.com
Background: Coronavirus disease 19 (COVID-19) can develop into a severe respiratory
syndrome that results in up to 40% mortality. Acute lung inflammatory edema is a major …
syndrome that results in up to 40% mortality. Acute lung inflammatory edema is a major …
[HTML][HTML] Outcome of SARS-CoV-2 infection in 121 patients with inborn errors of immunity: a cross-sectional study
…, E de Oliveira Dantas, S Pestana, E Mansour… - Journal of clinical …, 2021 - Springer
Purpose There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of
Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of …
Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of …
[HTML][HTML] Asthma and COVID-19: a systematic review
Background Severe coronavirus disease-19 (COVID-19) presents with progressive dyspnea,
which results from acute lung inflammatory edema leading to hypoxia. As with other …
which results from acute lung inflammatory edema leading to hypoxia. As with other …
First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes
…, L de Souza Moura, E Talesnik, E Mansour… - Journal of clinical …, 2014 - Springer
Hyper-IgM (HIGM) syndrome is a heterogeneous group of disorders characterized by normal
or elevated serum IgM levels associated with absent or decreased IgG, IgA and IgE. Here …
or elevated serum IgM levels associated with absent or decreased IgG, IgA and IgE. Here …
[HTML][HTML] Plasma angiotensin II is increased in critical coronavirus disease 2019
…, B Bombassaro, M Monfort-Pires, E Mansour… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) employs angiotensin-converting
enzyme 2 (ACE2) as its receptor for cell entrance, and studies have suggested that …
enzyme 2 (ACE2) as its receptor for cell entrance, and studies have suggested that …
Hereditary angioedema with normal C1 inhibitor and F12 mutations in 42 Brazilian families
…, N Cagini, RF Gonçalves, E Mansour… - The Journal of Allergy …, 2018 - Elsevier
Background Hereditary angioedema (HAE) with normal C1 inhibitor (C1-INH) is a rare
condition with clinical features similar to those of HAE with C1-INH deficiency. Mutations in the …
condition with clinical features similar to those of HAE with C1-INH deficiency. Mutations in the …
Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19
Coagulation activation is a prominent feature of severe acute respiratory syndrome
coronavirus 2 (COVID-19) infection. Activation of the contact system and intrinsic pathway has …
coronavirus 2 (COVID-19) infection. Activation of the contact system and intrinsic pathway has …
SARS-CoV-2 uses CD4 to infect T helper lymphocytes
… C Silva-Costa; Andre Palma; Eli Mansour; Raisa G. Ulaf; Ana F. Bernardes; Thyago A. …
Eli Mansour; Department of Internal Medicine, School of Medical Sciences, University of …
Eli Mansour; Department of Internal Medicine, School of Medical Sciences, University of …
[HTML][HTML] Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized …
E Mansour, FF Bueno, JC de Lima-Júnior, A Palma… - Trials, 2021 - Springer
Background SARS-CoV-2, the virus that causes COVID-19, enters the cells through a mechanism
dependent on its binding to angiotensin-converting enzyme 2 (ACE2), a protein highly …
dependent on its binding to angiotensin-converting enzyme 2 (ACE2), a protein highly …
